Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

P

PVLA

Palvella Therapeutics Inc

157.77

Aug 07 • 3:59 PM ET +2.84 (1.83%)

157.77

Aftermarket • 7:34 PM ET 0.00 (0.00%)

Healthcare Biotechnology USA Mid NASD

Peers: KYMR MANE ORKA RYTM KRYS BMRN CRNX INCY AXSM NBIX

| Held by: XBI VTI IWM VXF IWO VTWO VHT VFMO LFSC LABU

Scroll to Statements

Index	RUT
Market Cap	2.27B
Enterprise Value	2.03B
Income	-49.30M
Sales	0.00M
Book/sh	16.23
Cash/sh	18.17
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	29
IPO	Jan 02, 2015

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	9.72
P/C	8.68
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	28.88
Current Ratio	28.88
Debt/Eq	0.09
LT Debt/Eq	0.09
Option/Short	Yes / Yes

EPS (ttm)	-4.17
EPS next Y	-7.81
EPS next Q	-1.77
EPS this Y	-73.62%
EPS next Y	-21.24%
EPS next 5Y	-11.12%
EPS past 3/5Y	53.08% 41.62%
Sales past 3/5Y	- -
EPS Y/Y TTM	66.94%
Sales Y/Y TTM	-
EPS Q/Q	-62.12%
Sales Q/Q	-
Earnings	Aug 04 BMO
EPS/Sales Surpr.	-29.55% -

Insider Own	29.40%
Insider Trans	-0.45%
Inst Own	89.62%
Inst Trans	29.13%
ROA	-28.73%
ROE	-34.25%
ROIC	-19.52%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	8.02%
SMA50	18.41%
SMA200	41.59%
Trades

Shs Outstand	14.31M
Shs Float	10.17M
Short Float	21.41%
Short Ratio	8.30
Short Interest	2.18M
52W High	161.38 -2.24%
52W Low	37.33 322.64%
Volatility	6.65% 7.86%
ATR (14)	10.11
RSI (14)	59.72
Beta	-0.23
Rel Volume	0.69
Avg Volume	262.35K
Volume	182,300

Perf Week	13.47%
Perf Month	4.46%
Perf Quarter	39.30%
Perf Half Y	106.42%
Perf YTD	50.73%
Perf Year	304.02%
Perf 3Y	791.96%
Perf 5Y	-48.10%
Perf 10Y	17.39%
Recom	1.00
Target Price	229.82
Prev Close	154.93
Price	157.77
Change %	1.83%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)